These findings suggest that chronic activation of RASFs by RANTES/CCL5 or cytokines such as IL-1β during the disease progression leads to the subtle structural changes in the native collagen of the cartilage that eventually contribute to the tissue destruction in RA. This evidence concerns the gene IL1B and rheumatoid arthritis.